top of page
Chief Technology Officer(CTO), Chi-Tang Tu, Ph.D.
Dr. Cheng has many years of cell therapy product development experience and qualifications in biotechnology company management. He was the general manager of a listed stem cell biomedical park branch. During his tenure, he led the development of a new drug for stem cell treatment of cirrhosis / fibrosis (GXHPC1). Industry-academia cooperation, technology transfer, entry into the Hsinchu Biomedical Park, establishment of a clinical cell laboratory in compliance with GTP, GXHPC1 passed new drug development regulations, set the GXHPC1 process and product specifications, GXHPC1 prototype and trial production, and promoted GXHPC1 preclinical Trials (including effectiveness tests, safety tests, and CMC data establishment), applicant clinical trials (including GTP field visits by TFDA, review of relevant responses), and the introduction of ISO 9001, ISO 17025, and GTP quality systems, and develop a health food can increase endogenous stem cells. Dr. Cheng received doctor of Engineering from National Tsing Hua University, master of Management Science from National Cheng Kung University, and holds several international certificates, such as PMP, NPDP.
Stem cell R&D Supervisor, Kuo-Wei Hsueh, Ph.D.
Dr. Hsueh is Aging Medicine Ph.D. of China Medical University. His experience has postdoctoral researcher in Hualien Tzu Chi Hospital. His expertise is cell therapy and small molecule drug development for research on Amyotrophic lateral sclerosis, stem cell culture and regenerative medicine, and development of cell products for clinical applications.
Mitochondrion R&D Supervisor, Chih-Kai Hsu, Ph.D.
Dr. Hus is Biomedical Ph.D. of Chang Gung University. His experience has Clinical Admission of Chang Gung Hospital and postdoctoral researcher in the Stem Cell Group of National Institute of Health Biomedicine. His expertise is immunology, respiratory system, stem cell regenerative medicine and 3D bioprinting.
Product R&D Supervisor, Shun-Chieh Yang, Ph.D.
Dr. Yang is Biochemistry and Biotechnology Ph.D. of Chung Shan Medical University. His experience has postdoctoral researcher in the environmental health group of the National Institutes of Health. His expertise is herbal extracting, establishing and validating animal models for efficacy, developing cell platforms, and product development.
bottom of page